Multiple methods within a single trial [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 17:44  – Posting: # 20027
Views: 2,078

Dear Ohlbe,

» I would reverse the question: why would you use two different methods, or two different technologies, within a single BE trial, with the risk of increasing variability? We're not talking of 2 different trials here (where one can be done at one CRO and the other at another CRO, with a different method).

Please think about very big clinical trials which required a multi-centers ( e.g for Anti-cancer drugs), you deal here with different CRO's which could have different technologies.

Best regards,


Complete thread:

 Admin contact
20,254 posts in 4,262 threads, 1,398 registered users;
online 10 (0 registered, 10 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 04:33 UTC

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz